A detailed history of Van Eck Associates Corp transactions in Viatris Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 1,170,630 shares of VTRS stock, worth $14.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,170,630
Previous 1,014,429 15.4%
Holding current value
$14.7 Million
Previous $10.8 Million 25.39%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$10.32 - $12.13 $1.61 Million - $1.89 Million
156,201 Added 15.4%
1,170,630 $13.5 Million
Q2 2024

Jul 31, 2024

BUY
$10.05 - $12.02 $474,902 - $567,993
47,254 Added 4.89%
1,014,429 $10.8 Million
Q1 2024

Apr 30, 2024

SELL
$11.27 - $13.53 $3.18 Million - $3.82 Million
-282,195 Reduced 22.59%
967,175 $11.5 Million
Q4 2023

Feb 05, 2024

SELL
$8.77 - $10.85 $4.17 Million - $5.16 Million
-475,169 Reduced 27.55%
1,249,370 $13.5 Million
Q3 2023

Nov 08, 2023

SELL
$9.59 - $11.35 $543,398 - $643,125
-56,663 Reduced 3.18%
1,724,539 $17 Million
Q2 2023

Aug 03, 2023

BUY
$9.02 - $10.29 $4.87 Million - $5.55 Million
539,436 Added 43.44%
1,781,202 $17.8 Million
Q1 2023

May 03, 2023

SELL
$9.2 - $12.26 $9.72 Million - $12.9 Million
-1,056,139 Reduced 45.96%
1,241,766 $11.9 Million
Q4 2022

Feb 08, 2023

BUY
$8.72 - $11.56 $2.62 Million - $3.47 Million
300,343 Added 15.04%
2,297,905 $25.6 Million
Q3 2022

Oct 27, 2022

SELL
$8.48 - $11.13 $2.54 Million - $3.33 Million
-299,610 Reduced 13.04%
1,997,562 $17 Million
Q2 2022

Aug 03, 2022

BUY
$9.95 - $12.27 $7.16 Million - $8.82 Million
719,175 Added 45.58%
2,297,172 $24.1 Million
Q1 2022

May 10, 2022

BUY
$9.81 - $15.4 $2.77 Million - $4.35 Million
282,666 Added 21.82%
1,577,997 $17.2 Million
Q4 2021

Jan 26, 2022

BUY
$12.09 - $14.68 $3.13 Million - $3.81 Million
259,285 Added 25.03%
1,295,331 $17.5 Million
Q3 2021

Nov 03, 2021

BUY
$13.25 - $15.13 $4.55 Million - $5.2 Million
343,642 Added 49.63%
1,036,046 $14 Million
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $658,447 - $819,887
-50,767 Reduced 6.83%
692,404 $9.9 Million
Q1 2021

May 13, 2021

BUY
$13.59 - $18.54 $1.28 Million - $1.75 Million
94,434 Added 14.56%
743,171 $10.4 Million
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $9.28 Million - $12.2 Million
648,737 New
648,737 $12.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.